{"count": 12, "results": [{"_id": "39797377", "pmid": 39797377, "title": "The Impact of Diabetes Mellitus and Metformin Use on Outcomes After Endovascular Aneurysm Repair.", "journal": "J Clin Med", "authors": ["van Merrienboer TAR", "Warlich V", "Holewijn S", "Driessen W", "Yeung KK", "Reijnen MMPJ"], "date": "2025-01-06T00:00:00Z", "doi": "10.3390/jcm14010295", "meta_date_publication": "2025 Jan 6", "meta_volume": "14", "meta_issue": "1", "meta_pages": "", "score": 50264.31, "text_hl": "The Impact of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes Mellitus@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use on Outcomes After Endovascular @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@Aneurysm@@@ Repair.", "citations": {"NLM": "van Merrienboer TAR, Warlich V, Holewijn S, Driessen W, Yeung KK, Reijnen MMPJ. The Impact of Diabetes Mellitus and Metformin Use on Outcomes After Endovascular Aneurysm Repair. J Clin Med. 2025 Jan 6;14(1):. PMID: 39797377", "BibTeX": "@article{39797377, title={The Impact of Diabetes Mellitus and Metformin Use on Outcomes After Endovascular Aneurysm Repair.}, author={van Merrienboer TAR and Warlich V and Holewijn S and Driessen W and Yeung KK and Reijnen MMPJ}, journal={J Clin Med}, volume={14}, number={1}}"}}, {"_id": "34617056", "pmid": 34617056, "pmcid": "PMC8489247", "title": "Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E-deficient mice", "journal": "JVS Vasc Sci", "authors": ["Kunath A", "Unosson J", "Friederich-Persson M", "Bjarnegård N", "Becirovic-Agic M", "Björck M", "Mani K", "Wanhainen A", "Wågsäter D"], "date": "2021-03-03T00:00:00Z", "doi": "10.1016/j.jvssci.2020.11.031", "meta_date_publication": "2021", "meta_volume": "2", "meta_issue": "", "meta_pages": "33-42", "score": 50261.61, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibition of experimental @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@ formation in mice", "citations": {"NLM": "Kunath A, Unosson J, Friederich-Persson M, Bjarnegård N, Becirovic-Agic M, Björck M, Mani K, Wanhainen A, Wågsäter D. Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E-deficient mice JVS Vasc Sci. 2021;2():33-42. PMID: 34617056", "BibTeX": "@article{34617056, title={Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E-deficient mice}, author={Kunath A and Unosson J and Friederich-Persson M and Bjarnegård N and Becirovic-Agic M and Björck M and Mani K and Wanhainen A and Wågsäter D}, journal={JVS Vasc Sci}, volume={2}, pages={33-42}}"}}, {"_id": "34961561", "pmid": 34961561, "pmcid": "PMC8710921", "title": "Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm", "journal": "Trials", "authors": ["Golledge J", "Arnott C", "Moxon J", "Monaghan H", "Norman R", "Morris D", "Li Q", "Jones G", "Roake J", "Bown M", "Neal B"], "date": "2021-12-27T00:00:00Z", "doi": "10.1186/s13063-021-05915-0", "meta_date_publication": "2021 Dec 27", "meta_volume": "22", "meta_issue": "1", "meta_pages": "962", "score": 50260.887, "text_hl": "Protocol for the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@Aneurysm@@@ Trial (MAT): a placebo-controlled randomised trial testing whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces the risk of serious complications of @DISEASE_Aortic_Aneurysm_Abdominal @DISEASE_MESH:D017544 @@@abdominal aortic aneurysm@@@", "citations": {"NLM": "Golledge J, Arnott C, Moxon J, Monaghan H, Norman R, Morris D, Li Q, Jones G, Roake J, Bown M, Neal B. Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm Trials. 2021 Dec 27;22(1):962. PMID: 34961561", "BibTeX": "@article{34961561, title={Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm}, author={Golledge J and Arnott C and Moxon J and Monaghan H and Norman R and Morris D and Li Q and Jones G and Roake J and Bown M and Neal B}, journal={Trials}, volume={22}, number={1}, pages={962}}"}}, {"_id": "36777816", "pmid": 36777816, "pmcid": "PMC9912973", "title": "Netrin-1 Monoclonal Antibody-Functionalized Nanoparticle Loaded with Metformin Prevents the Progression of Abdominal Aortic Aneurysms", "journal": "Int J Nanomedicine", "authors": ["Zhang Z", "Zhuang J", "Sun D", "Ding Q", "Zheng H", "Li H", "Zhang X", "Du Y", "Ma T", "Meng Q"], "date": "2023-02-06T00:00:00Z", "doi": "10.2147/IJN.S400993", "meta_date_publication": "2023", "meta_volume": "18", "meta_issue": "", "meta_pages": "627-639", "score": 50259.492, "text_hl": "Recently, the therapeutic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysms@@@ has attracted considerable interest. ", "citations": {"NLM": "Zhang Z, Zhuang J, Sun D, Ding Q, Zheng H, Li H, Zhang X, Du Y, Ma T, Meng Q. Netrin-1 Monoclonal Antibody-Functionalized Nanoparticle Loaded with Metformin Prevents the Progression of Abdominal Aortic Aneurysms Int J Nanomedicine. 2023;18():627-639. PMID: 36777816", "BibTeX": "@article{36777816, title={Netrin-1 Monoclonal Antibody-Functionalized Nanoparticle Loaded with Metformin Prevents the Progression of Abdominal Aortic Aneurysms}, author={Zhang Z and Zhuang J and Sun D and Ding Q and Zheng H and Li H and Zhang X and Du Y and Ma T and Meng Q}, journal={Int J Nanomedicine}, volume={18}, pages={627-639}}"}}, {"_id": "38509639", "pmid": 38509639, "title": "Comment on: Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth.", "journal": "Br J Surg", "authors": ["Manenti A", "Manco G", "Silingardi R", "Coppi F"], "date": "2024-03-02T00:00:00Z", "doi": "10.1093/bjs/znae055", "meta_date_publication": "2024 Mar 2", "meta_volume": "111", "meta_issue": "3", "meta_pages": "", "score": 50257.414, "text_hl": "Comment on: Influence of cardiometabolic medications on @DISEASE_Aortic_Aneurysm_Abdominal @DISEASE_MESH:D017544 @@@abdominal aortic aneurysm@@@ growth in the UK @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@Aneurysm@@@ Growth Study: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and angiotensin-converting enzyme inhibitors associated with slower @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@ growth.", "citations": {"NLM": "Manenti A, Manco G, Silingardi R, Coppi F. Comment on: Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth. Br J Surg. 2024 Mar 2;111(3):. PMID: 38509639", "BibTeX": "@article{38509639, title={Comment on: Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth.}, author={Manenti A and Manco G and Silingardi R and Coppi F}, journal={Br J Surg}, volume={111}, number={3}}"}}, {"_id": "37168662", "pmid": 37168662, "pmcid": "PMC10165270", "title": "Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms", "journal": "JVS Vasc Sci", "authors": ["Xu B", "Li G", "Li Y", "Deng H", "Cabot A", "Guo J", "Samura M", "Zheng X", "Chen T", "Zhao S", "Fujimura N", "Dalman RL"], "date": "2023-03-31T00:00:00Z", "doi": "10.1016/j.jvssci.2023.100102", "meta_date_publication": "2023", "meta_volume": "4", "meta_issue": "", "meta_pages": "100102", "score": 50251.402, "text_hl": "The mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-mediated @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@ suppression, and its efficacy in suppressing established experimental @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysms@@@, remain uncertain.", "citations": {"NLM": "Xu B, Li G, Li Y, Deng H, Cabot A, Guo J, Samura M, Zheng X, Chen T, Zhao S, Fujimura N, Dalman RL. Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms JVS Vasc Sci. 2023;4():100102. PMID: 37168662", "BibTeX": "@article{37168662, title={Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms}, author={Xu B and Li G and Li Y and Deng H and Cabot A and Guo J and Samura M and Zheng X and Chen T and Zhao S and Fujimura N and Dalman RL}, journal={JVS Vasc Sci}, volume={4}, pages={100102}}"}}, {"_id": "34394010", "pmid": 34394010, "pmcid": "PMC8355809", "title": "The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Yuan Z", "Heng Z", "Lu Y", "Wei J", "Cai Z"], "date": "2021-07-28T00:00:00Z", "doi": "10.3389/fendo.2021.721213", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "721213", "score": 50248.438, "text_hl": "This study concluded that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prescription was associated with decreased hazard of @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@ formation. ", "citations": {"NLM": "Yuan Z, Heng Z, Lu Y, Wei J, Cai Z. The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis Front Endocrinol (Lausanne). 2021;12():721213. PMID: 34394010", "BibTeX": "@article{34394010, title={The Protective Effect of Metformin on Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis}, author={Yuan Z and Heng Z and Lu Y and Wei J and Cai Z}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={721213}}"}}, {"_id": "37559446", "pmid": 37559446, "pmcid": "PMC10415166", "title": "Novel pharmacological approaches in abdominal aortic aneurysm", "journal": "Clin Sci (Lond)", "authors": ["Puertas-Umbert L", "Almendra-Pegueros R", "Jiménez-Altayó F", "Sirvent M", "Galán M", "Martínez-González J", "Rodríguez C"], "date": "2023-08-14T00:00:00Z", "doi": "10.1042/CS20220795", "meta_date_publication": "2023 Aug 14", "meta_volume": "137", "meta_issue": "15", "meta_pages": "1167-1194", "score": 50240.504, "text_hl": "It should be noted, however, that although cohort studies and case-control studies support the ability of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to ameliorate @DISEASE_Aortic_Aneurysm_Abdominal @DISEASE_MESH:D017544 @@@AAA@@@ progression and @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@-related events, randomised controlled trials are needed to state this assumption more clearly. ", "citations": {"NLM": "Puertas-Umbert L, Almendra-Pegueros R, Jiménez-Altayó F, Sirvent M, Galán M, Martínez-González J, Rodríguez C. Novel pharmacological approaches in abdominal aortic aneurysm Clin Sci (Lond). 2023 Aug 14;137(15):1167-1194. PMID: 37559446", "BibTeX": "@article{37559446, title={Novel pharmacological approaches in abdominal aortic aneurysm}, author={Puertas-Umbert L and Almendra-Pegueros R and Jiménez-Altayó F and Sirvent M and Galán M and Martínez-González J and Rodríguez C}, journal={Clin Sci (Lond)}, volume={137}, number={15}, pages={1167-1194}}"}}, {"_id": "38055889", "pmid": 38055889, "pmcid": "PMC10763526", "title": "Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth", "journal": "Br J Surg", "authors": ["Gellatly C", "Sweeting M", "Emin A", "Katsogridakis E", "Finch S", "Saratzis A", "Bown MJ", "UKAGS Investigators and Collaborators"], "date": "2023-12-06T00:00:00Z", "doi": "10.1093/bjs/znad375", "meta_date_publication": "2023 Dec 6", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50237.883, "text_hl": "Influence of cardiometabolic medications on @DISEASE_Aortic_Aneurysm_Abdominal @DISEASE_MESH:D017544 @@@abdominal aortic aneurysm@@@ growth in the UK @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@Aneurysm@@@ Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@ growth", "citations": {"NLM": "Gellatly C, Sweeting M, Emin A, Katsogridakis E, Finch S, Saratzis A, Bown MJ, UKAGS Investigators and Collaborators. Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth Br J Surg. 2023 Dec 6;():. PMID: 38055889", "BibTeX": "@article{38055889, title={Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth}, author={Gellatly C and Sweeting M and Emin A and Katsogridakis E and Finch S and Saratzis A and Bown MJ and UKAGS Investigators and Collaborators}, journal={Br J Surg}}"}}, {"_id": "29190959", "pmid": 29190959, "pmcid": "PMC5696225", "title": "Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms", "journal": "Oncotarget", "authors": ["Yang L", "Shen L", "Gao P", "Li G", "He Y", "Wang M", "Zhou H", "Yuan H", "Jin X", "Wu X"], "date": "2017-10-07T00:00:00Z", "doi": "10.18632/oncotarget.21608", "meta_date_publication": "2017 Nov 3", "meta_volume": "8", "meta_issue": "54", "meta_pages": "92827-92840", "score": 50053.188, "text_hl": "(Figure 6C) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment also preserved the collagen and SMCs in the wall of @<m>DISEASE_Aneurysm</m> @DISEASE_MESH:D000783 @@@aneurysm@@@. ", "citations": {"NLM": "Yang L, Shen L, Gao P, Li G, He Y, Wang M, Zhou H, Yuan H, Jin X, Wu X. Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms Oncotarget. 2017 Nov 3;8(54):92827-92840. PMID: 29190959", "BibTeX": "@article{29190959, title={Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms}, author={Yang L and Shen L and Gao P and Li G and He Y and Wang M and Zhou H and Yuan H and Jin X and Wu X}, journal={Oncotarget}, volume={8}, number={54}, pages={92827-92840}}"}}]}